Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Imaging Study Reveals a Clue to Schizophrenia

By HospiMedica staff writers
Posted on 08 Jan 2001
A magnetic resonance (MR) brain imaging study has revealed that the thalamus, the brain's main sensory filter, is smaller than normal from the earliest stages of schizophrenia. More...
The study, conducted by researchers at the Institute of Psychiatry (London, UK), was published in the January issue of the American Journal of Psychiatry.

The thalamus is of particular interest in schizophrenia because it is the area of the brain where information is received and relayed to other areas. It receives information by way of the senses, which is then filtered and passed to the proper regions for processing. Schizophrenia patients often have difficulty in processing information properly and, as a result, may experience brain overload in some areas.

The study involved 67 participants, of whom 38 were experiencing their first episode of psychosis and 29 were healthy volunteers. In contrast to other studies, 13 of the schizophrenia patients had no or little experience of antipsychotic medication. MRI scans identified differences in the thalamus between the two groups. The results showed that even in the earliest stages of schizophrenia, the thalamus was smaller than in healthy people. The researchers say these findings along with other findings that schizophrenia patients have decreased gray matter at the earliest stages of the illness suggest a role for brain imaging to pinpoint warning signs of illness and perhaps even prevent its development.

"This study reveals that there is a fundamental problem in the hub of the brain,” says Dr. Tonmoy Sharma, leader of the study. "If you think of the brain in terms of networks, it is like making a phone call when the line is not connected properly. The call can't be made, or you may get through to the wrong person. It is the same in the brain.”

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.